Thermosensitive and mucoadhesive gels containing solid lipid nanoparticles loaded with fluconazole and niosomes loaded with clindamycin for the treatment of periodontal diseases: a laboratory experiment

BMC Oral Health. 2024 May 11;24(1):551. doi: 10.1186/s12903-024-04322-6.

Abstract

Background: Periodontal diseases may benefit more from topical treatments with nanoparticles rather than systemic treatments due to advantages such as higher stability and controlled release profile. This study investigated the preparation and characterization of thermosensitive gel formulations containing clindamycin-loaded niosomes and solid lipid nanoparticles (SLNs) loaded with fluconazole (FLZ), as well as their in vitro antibacterial and antifungal effects in the treatment of common microorganisms that cause periodontal diseases.

Methods: This study loaded niosomes and SLNs with clindamycin and FLZ, respectively, and assessed their loading efficiency, particle size, and zeta potential. The particles were characterized using a variety of methods such as differential scanning calorimetry (DSC), dynamic light scattering (DLS), and Transmission Electron Microscopy (TEM). Thermosensitive gels were formulated by combining these particles and their viscosity, gelation temperature, in-vitro release profile, as well as antibacterial and antifungal effects were evaluated.

Results: Both types of these nanoparticles were found to be spherical (TEM) with a mean particle size of 243.03 nm in niosomes and 171.97 nm in SLNs (DLS), and respective zeta potentials of -23.3 and -15. The loading rate was 98% in niosomes and 51% in SLNs. The release profiles of niosomal formulations were slower than those of the SLNs. Both formulations allowed the release of the drug by first-order kinetic. Additionally, the gel formulation presented a slower release of both drugs compared to niosomes and SLNs suspensions.

Conclusion: Thermosensitive gels containing clindamycin-loaded niosomes and/or FLZ-SLNs were found to effectively fight the periodontitis-causing bacteria and fungi.

Keywords: Clindamycin; Fluconazole; Niosomes; Periodontal disease; SLNs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / pharmacology
  • Calorimetry, Differential Scanning
  • Candida albicans / drug effects
  • Clindamycin* / administration & dosage
  • Clindamycin* / therapeutic use
  • Fluconazole* / administration & dosage
  • Fluconazole* / pharmacology
  • Gels*
  • Humans
  • Lipids / chemistry
  • Liposomes*
  • Microscopy, Electron, Transmission
  • Nanoparticles* / chemistry
  • Particle Size*
  • Periodontal Diseases* / drug therapy
  • Temperature
  • Viscosity

Substances

  • Clindamycin
  • Gels
  • Fluconazole
  • Liposomes
  • Antifungal Agents
  • Anti-Bacterial Agents
  • Lipid Nanoparticles
  • Lipids